Does pretreatment of bone marrow mesenchymal stem cells with 5-azacytidine or double intravenous infusion improve their therapeutic potential for dilated cardiomyopathy?
Medical Science Monitor Basic Research · 2013
DOI: 10.12659/msmbr.883737 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Science Monitor Basic Research, 2013. Verfasst von Sirui Yang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Cardiology, First Affiliated Hospital of Jilin University, Changchun, Jilin Province, China. Hauptthemen laut MEDLINE: Mesenchymal Stem Cell Transplantation. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Cardiology, First Affiliated Hospital of Jilin University, Changchun, Jilin Province, China.
Zitieren
APA
Yang, S., Piao, J., Jin, L., & Zhou, Y. (2013). Does pretreatment of bone marrow mesenchymal stem cells with 5-azacytidine or double intravenous infusion improve their therapeutic potential for dilated cardiomyopathy?. Medical Science Monitor Basic Research. https://doi.org/10.12659/msmbr.883737
Vancouver
Yang S, Piao J, Jin L, Zhou Y. Does pretreatment of bone marrow mesenchymal stem cells with 5-azacytidine or double intravenous infusion improve their therapeutic potential for dilated cardiomyopathy?. Medical Science Monitor Basic Research. 2013. doi:10.12659/msmbr.883737
BibTeX
@article{Yang2013,
author = {Yang, Sirui and Piao, Jinhua and Jin, Lianhua and Zhou, Yan},
title = {Does pretreatment of bone marrow mesenchymal stem cells with 5-azacytidine or double intravenous infusion improve their therapeutic potential for dilated cardiomyopathy?},
journal = {Medical Science Monitor Basic Research},
year = {2013},
doi = {10.12659/msmbr.883737}
}
EUVIMED